Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT06055959

A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

Conditions: Generalized Myasthenia Gravis

Sex: All

Ages: 12 Years – 17 Years

Healthy volunteers: No

Phase: PHASE2, PHASE3

Enrollment: 8

Sponsor: UCB Biopharma SRL

Location: Mg0014 50168 Chicago Illinois

Summary

The purpose of this study is to assess the pharmacokinetics, pharmacodynamics, safety, tolerability, immunogenicity and activity of zilucoplan (ZLP) in pediatric study participants with generalized myasthenia gravis (gMG).

Eligibility Criteria

Inclusion Criteria: United States of America (USA) specific inclusion criterion: \- Participant must be 12 to \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06055959). StuddyBuddy aggregates publicly available trial information.